Methamphetamine preconditioning causes differential changes in striatal transcriptional responses to large doses of the drug

Dose-Response

Volumn 9, Issue 2, 2011, Pages 165-181

  Cadet, Jean Lud ^a   Brannock, Christie ^a   Ladenheim, Bruce ^a   McCoy, Michael T ^a   Beauvais, Genevieve ^a   Hodges, Amber B ^a   Lehrmann, Elin ^b   Wood III, William H ^b   Becker, Kevin G ^b   Krasnova, Irina N ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

BDNF; Heat shock proteins; Methamphetamine; Preconditioning; Striatum

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HEAT SHOCK PROTEIN 27; HEME OXYGENASE 1; METHAMPHETAMINE; SMALL HEAT SHOCK PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; MICROARRAY ANALYSIS; NEUROPROTECTION; NONHUMAN; RAT; RNA EXTRACTION; RNA HYBRIDIZATION; STIMULUS RESPONSE;

EID: 79958702945     PISSN: None     EISSN: 15593258     Source Type: Journal    
DOI: 10.2203/dose-response.10-011.Cadet     Document Type: Article

References (60)

1. Arrigo AP. 2007. The cellular "networking" of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. Adv Exp Med Biol 594:14-26
2. Arya R, Mallik M, and Lakhotia SC. 2007. Heat shock genes -integrating cell survival and death. J Biosci 32:595-610
3. Cadet JL and Krasnova IN. 2009. Cellular and molecular neurobiology of brain preconditioning. Mol Neurobiol 39:50-61
4. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, and Epstein C. 1994. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383
5. Cadet JL, Ordonez SV, and Ordonez JV. 1997. Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse 25:176-184
6. Cadet JL, Jayanthi S, McCoy MT, Vawter M, and Ladenheim B. 2001. Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array. Synapse 41:40-48
7. Cadet JL, Jayanthi S, and Deng X. 2003. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. Faseb J 17:1775-1788
8. Cadet JL, Krasnova IN, Jayanthi S, and Lyles J. 2007. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res 11:183-202
9. Cadet JL, Krasnova IN, Ladenheim B, Cai NS, McCoy MT, and Atianjoh FE. 2009a. Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain. Neurotox Res 15:252-259
10. Cadet JL, McCoy MT, Cai NS, Krasnova IN, Ladenheim B, Beauvais G, Wilson N, Wood W, Becker KG, and Hodges AB. 2009b. Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum. PLoS One 4:e7812
11. Calabrese EJ. 2008. Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson Law are manifestations of hormesis. Ageing Res Rev 7:8-20
12. Calabrese V, Stella AM, Butterfield DA, and Scapagnini G. 2004. Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. Antioxid Redox Signal 6:895-913
13. Canudas AM, Pezzi S, Canals JM, Pallas M, and Alberch J. 2005. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury. Brain Res Mol Brain Res 134:147-154
14. Cass WA, Peters LE, Harned ME, and Seroogy KB. 2006. Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine. Ann N Y Acad Sci 1074:272-281
15. Chang L, Alicata D, Ernst T, and Volkow N. 2007. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102 Suppl 1:16-32
16. Danaceau JP, Deering CE, Day JE, Smeal SJ, Johnson-Davis KL, Fleckenstein AE, and Wilkins DG. 2007. Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur J Pharmacol 559:46-54
17. Darke S, Kaye S, McKetin R, and Duflou J. 2008. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 27:253-262
18. Deng X, Ladenheim B, Tsao LI, and Cadet JL. 1999. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci 19:10107-10115
19. Dennis KE, and Levitt P. 2005. Regional expression of brain derived neurotrophic factor (BDNF) is correlated with dynamic patterns of promoter methylation in the developing mouse forebrain. Brain Res Mol Brain Res 140:1-9
20. Dhodda VK, Sailor KA, Bowen KK, and Vemuganti R. 2004. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 89:73-89
21. Dirnagl U, Simon RP, and Hallenbeck JM. 2003. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26:248-254
22. Franklin TB, Krueger-Naug AM, Clarke DB, Arrigo AP, and Currie RW. 2005. The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. Int J Hyperthermia 21:379-392
23. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, and Solary E. 1999. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. Faseb J 13:2061-2070
24. Gozzelino R, Jeney V, and Soares MP. 2010. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50:323-354
25. Graham DL, Noailles PA, and Cadet JL. 2008. Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges. J Neurochem 105:1873-1885
26. Hu Z, Yang B, Lu W, Zhou W, Zeng L, Li T, and Wang X. 2008. HSPB2/MKBP, a novel and unique member of the small heat-shock protein family. J Neurosci Res 86:2125-2133
27. Huang YN, Wu CH, Lin TC, and Wang JY. 2009. Methamphetamine induces heme oxygenase-1 expression in cortical neurons and glia to prevent its toxicity. Toxicol Appl Pharmacol 240:315-326.
28. Itoh N and Ornitz DM. 2008. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 237:18-27
29. Jayanthi S, Deng X, Bordelon M, McCoy MT, and Cadet JL. 2001. Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. Faseb J 15:1745-1752
30. Jayanthi S, McCoy MT, Beauvais G, Ladenheim B, Gilmore K, Wood W, 3rd, Becker K, and Cadet JL. 2009. Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum. PLoS One 4:e6092
31. Johnson-Davis KL, Fleckenstein AE, and Wilkins DG. 2003. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur J Pharmacol 482:151-154
32. Koerner IP, Gatting M, Noppens R, Kempski O, and Brambrink AM. 2007. Induction of cerebral ischemic tolerance by erythromycin preconditioning reprograms the transcriptional response to ischemia and suppresses inflammation. Anesthesiology 106:538-547.
33. Kramer JC, Fischman VS, and Littlefield DC. 1967. Amphetamine abuse. Pattern and effects of high doses taken intravenously. Jama 201:305-309
34. Krasnova IN and Cadet JL. 2009. Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379-407
35. Krasnova IN, Betts ES, Dada A, Jefferson A, Ladenheim B, Becker KG, Cadet JL, and Hohmann CF. 2007. Neonatal dopamine depletion induces changes in morphogenesis and gene expression in the developing cortex. Neurotox Res 11:107-130
36. Krasnova IN, Li SM, Wood WH, McCoy MT, Prabhu VV, Becker KG, Katz JL, Cadet JL. 2008. Transcriptional responses to reinforcing effects of cocaine in the rat hippocampus and cortex. Genes Brain Behav 7:193-202
37. Krasnova IN, Justinova Z, Ladenheim B, Jayanthi S, McCoy MT, Barnes C, Warner JE, Goldberg SR, and Cadet JL. 2010. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS One 5:e8790
38. Kuipers SD and Bramham CR. 2006. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel 9:580-586
39. Ladenheim B, Krasnova IN, Deng X, Oyler JM, Polettini A, Moran TH, Huestis MA, Cadet JL. 2000. Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol Pharmacol 58:1247-1256
40. Li C, Hossieny P, Wu BJ, Qawasmeh A, Beck K, and Stocker R. 2007. Pharmacologic induction of heme oxygenase-1. Antioxid Redox Signal 9:2227-2239
41. Morrison LE, Whittaker RJ, Klepper RE, Wawrousek EF, and Glembotski CC. 2004. Roles for alphaBcrystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model. Am J Physiol Heart Circ Physiol 286:H847-855
42. Muchowski PJ and Wacker JL. 2005. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6:11-22
43. Murray JB. 1998. Psychophysiological aspects of amphetamine-methamphetamine abuse. J Psychol 132:227-237
44. Obrenovitch TP. 2008. Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 88:211-247
45. Rutkowski DT, Kang SW, Goodman AG, Garrison JL, Taunton J, Katze MG, Kaufman RJ, and Hegde RS. 2007. The role of p58IPK in protecting the stressed endoplasmic reticulum. Mol Biol Cell 18:3681-3691
46. Schmidt M. 2008. GABA(C) receptors in retina and brain. Results Probl Cell Differ 44:49-67
47. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, and Grant I. 2007. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275-297
48. Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, and Mori N. 2003. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 160:1699-1701
49. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, and Mori N. 2006. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63:90-100
50. Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ, Suda S, Suzuki K, Kawai M, Takebayashi K, Yamamoto S, Matsuzaki H, Ueki T, Mori N, Gold MS, and Cadet JL. 2008. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 28:5756-5761
51. Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, and Ling W. 2002. Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 21:61-74
52. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, and Simon RP. 2003. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362:1028-1037
53. Stenzel-Poore MP, Stevens SL, King JS, and Simon RP. 2007. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke 38:680-685
54. Surh YJ, Kundu JK, Li MH, Na HK, and Cha YN. 2009. Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Arch Pharm Res 32:1163-1176
55. Thomas DM, Francescutti-Verbeem DM, Liu X, and Kuhn DM. 2004. Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment-an oligonucleotide microarray approach. J Neurochem 88:380-393
56. Thomas DM and Kuhn DM. 2005. Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J Neurochem 92:790-797
57. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, and Miller EN. 2001. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377-382
58. Voss OH, Batra S, Kolattukudy SJ, Gonzalez-Mejia ME, Smith JB, and Doseff AI. 2007. Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation. J Biol Chem 282:25088-25099
59. Wu X, Chen PS, Dallas S, Wilson B, Block ML, Wang CC, Kinyamu H, Lu N, Gao X, Leng Y, Chuang DM, Zhang W, Lu RB, and Hong JS. 2008. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 11:1123-1134
60. Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, and Iguchi M. 2004. Psychiatric symptoms in methamphetamine users. Am J Addict 13:181-190